Guj. Themis Bio.

42
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE942C01045
  • NSEID: GUJTHEM
  • BSEID: 506879
INR
330.75
12.05 (3.78%)
BSENSE

Feb 03

BSE+NSE Vol: 45.81 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -11.20% vs 14.45% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -11.60% vs 6.93% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 58.81% vs 30.08% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -17.56% vs 2.06% in Mar 2024

Compare Profit and Loss Results of Guj. Themis Bio.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
150.00
38.00
112.00
294.74%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
150.00
38.00
112.00
294.74%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-4.00
3.00
75.00%
Raw Materials Consumed
25.00
21.00
4.00
19.05%
Power & Fuel Cost
26.00
0.00
26.00
0%
Employee Cost
11.00
18.00
-7.00
-38.89%
Operating Expenses
8.00
1.00
7.00
700.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
0.00
4.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
81.00
45.00
36.00
80.00%
Operating Profit (PBDIT) excl Other Income
69.00
-7.00
76.00
1,085.71%
Other Income
1.00
21.00
-20.00
-95.24%
Operating Profit (PBDIT)
71.00
14.00
57.00
407.14%
Interest
0.00
6.00
-6.00
-100.00%
Profit before Depriciation and Tax
70.00
8.00
62.00
775.00%
Depreciation
5.00
3.00
2.00
66.67%
Profit Before Taxation & Exceptional Items
65.00
5.00
60.00
1,200.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
65.00
5.00
60.00
1,200.00%
Provision for Tax
16.00
1.00
15.00
1,500.00%
Profit After Tax
48.00
3.00
45.00
1,500.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
191.00
3.00
188.00
6,266.67%
Profit Available for appropriations
240.00
7.00
233.00
3,328.57%
Appropriations
240.00
7.00
233.00
3,328.57%
Equity Dividend (%)
67%
0%
67.00
Earnings Per Share
4.48
1.02
3.46
339.22%
Profit And Loss - Net Sales
Net Sales 150.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.20% vs 14.45% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 69.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.60% vs 6.93% in Mar 2024

Profit And Loss - Interest
Interest 0.36 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 58.81% vs 30.08% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 48.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -17.56% vs 2.06% in Mar 2024